The budget strengthens India's position as a global hub for clinical research. The Biopharma SHAKTI (Strategy for Healthcare Advancement Through Knowledge, Technology and Innovation) initiative, envisaging the creation of a network of over 1,000 accredited Indian clinical trial sites, will promote high-value services exports, and lead to skills development, knowledge transfer and early access to innovative therapies.